John N Pritchard
Overview
Explore the profile of John N Pritchard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haussermann S, Arendsen L, Pritchard J
Adv Drug Deliv Rev
. 2022 Oct;
191:114580.
PMID: 36273513
Adherence to inhaled treatments is a complex challenge for patients with chronic obstructive pulmonary disease (COPD) and asthma, it not only involves following the prescribed treatment plans but also administering...
2.
Pritchard J
Drug Des Devel Ther
. 2020 Aug;
14:3043-3055.
PMID: 32801643
Increases in global temperature are already having a significant impact on our climate. The hydrofluorocarbon (HFC) propellants used today in pressurized metered-dose inhalers (pMDIs) have global warming potential (GWP) many...
3.
Pritchard J, Hatley R, Denyer J, Hollen D
Ther Deliv
. 2018 Jan;
9(2):121-136.
PMID: 29325508
In the 24 years since first being marketed, the mesh nebulizer has been developed by five main manufacturers into a viable solution for the delivery of high-value nebulized drugs. Mesh...
4.
Berlinski A, Hollen D, Pritchard J, Hatley R
Respir Care
. 2017 Nov;
63(3):289-293.
PMID: 29162718
Background: Inhaled corticosteroids are used to treat pediatric asthma. The shaking of a pressurized metered-dose inhaler (pMDI) is required to ensure consistency of emitted dose. Delays between shaking and actuating...
5.
Pritchard J
Ther Deliv
. 2017 May;
8(6):391-399.
PMID: 28470113
In the later half of the 20th century, nebulized therapy was in decline, but in the 21st century the prospects for the expanded use of nebulized therapy within respiratory medicine...
6.
Hatley R, Parker J, Pritchard J, Hollen D
J Aerosol Med Pulm Drug Deliv
. 2016 Sep;
30(1):71-79.
PMID: 27635793
Background: Pressurized metered-dose inhalers (pMDIs) should be shaken before use to prevent creaming or sedimentation of the drugs in solution; however, data published on this topic are limited, and it...
7.
Roche N, Scheuch G, Pritchard J, Nopitsch-Mai C, Lakhani D, Saluja B, et al.
J Aerosol Med Pulm Drug Deliv
. 2016 Aug;
30(1):1-13.
PMID: 27537608
This article reports on discussions at the 2015 workshop cosponsored by the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) and the International Society for Aerosols in Medicine (ISAM),...
8.
Pritchard J
Int J Pharm
. 2015 Oct;
496(2):1069-72.
PMID: 26475968
Nebulized treatment is an important delivery option for the young, elderly, and those with severe chronic respiratory disease, but there is a lack of new nebulized drug products being produced...
9.
Pritchard J
Expert Opin Drug Deliv
. 2015 Jun;
12(11):1755-65.
PMID: 26067581
Introduction: Respiratory diseases remain a target for improved forms of inhalation therapy. However, there are neither regulatory preferences for one type of device over another, nor well-recognized guidelines. This guidance...
10.
Elphick M, Hollen D, Pritchard J, Nikander K, Hardaker L, Hatley R
Expert Opin Drug Deliv
. 2015 Mar;
12(8):1375-87.
PMID: 25758911
Introduction: Nebulizers are a common device choice for use when developing a new drug product, but the range of nebulizer devices available can make it difficult to select the right...